JP2005501532A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005501532A5 JP2005501532A5 JP2003506300A JP2003506300A JP2005501532A5 JP 2005501532 A5 JP2005501532 A5 JP 2005501532A5 JP 2003506300 A JP2003506300 A JP 2003506300A JP 2003506300 A JP2003506300 A JP 2003506300A JP 2005501532 A5 JP2005501532 A5 JP 2005501532A5
- Authority
- JP
- Japan
- Prior art keywords
- antigens
- examples
- derived
- pathogens
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29526501P | 2001-06-01 | 2001-06-01 | |
| PCT/US2002/017374 WO2002102828A2 (en) | 2001-06-01 | 2002-05-31 | Chimeric flavivirus vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005501532A JP2005501532A (ja) | 2005-01-20 |
| JP2005501532A5 true JP2005501532A5 (https=) | 2010-03-25 |
Family
ID=23136958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003506300A Pending JP2005501532A (ja) | 2001-06-01 | 2002-05-31 | キメラフラビウイルスベクター |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7569383B2 (https=) |
| EP (1) | EP1401859B1 (https=) |
| JP (1) | JP2005501532A (https=) |
| KR (1) | KR100921592B1 (https=) |
| CN (1) | CN1551782A (https=) |
| AU (1) | AU2002322026B2 (https=) |
| BR (1) | BR0210907A (https=) |
| CA (1) | CA2448971C (https=) |
| ES (1) | ES2439724T3 (https=) |
| PL (1) | PL371187A1 (https=) |
| WO (1) | WO2002102828A2 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6962708B1 (en) * | 1997-02-28 | 2005-11-08 | Acambis, Inc. | Chimeric flavivirus vaccines |
| CN1551782A (zh) * | 2001-06-01 | 2004-12-01 | ��������ķ������ | 嵌合黄病毒载体 |
| KR101074175B1 (ko) | 2002-01-15 | 2011-10-14 | 사노피 파스테르 바이오로직스 씨오 | 플라비바이러스 백신 |
| US20050002968A1 (en) * | 2002-01-15 | 2005-01-06 | Monath Thomas P. | Flavivirus vaccines |
| US20040259224A1 (en) * | 2002-05-31 | 2004-12-23 | Farshad Guirakhoo | Tetravalent Dengue vaccines |
| WO2004045529A2 (en) * | 2002-11-15 | 2004-06-03 | Acambis, Inc. | West nile virus vaccine |
| AU2007297801A1 (en) * | 2006-07-14 | 2008-03-27 | Sanofi Pasteur Biologics Co. | Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins |
| EP2069483A4 (en) * | 2006-09-29 | 2010-10-27 | Sanofi Pasteur Biologics Co | RECOMBINANT RHINOVIRAL VECTORS |
| FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| MX2009004862A (es) | 2006-11-07 | 2009-07-17 | Sanofi Pasteur Biologics Co | Estabilizacion de vacunas por liofilizacion. |
| EP2117589A4 (en) * | 2007-01-31 | 2010-07-21 | Sanofi Pasteur Biologics Co | FLAVIVIRUS VACCINE VECTOR AGAINST INFLUENZA VIRUS |
| WO2009030872A1 (en) * | 2007-09-07 | 2009-03-12 | Mats Axel Atterdag Persson | Materials and methods for the treatment of hepatitis c |
| CN101959527B (zh) | 2008-03-05 | 2016-04-20 | 赛诺菲巴斯德有限公司 | 一种使含佐剂的疫苗组合物稳定的方法 |
| JP5779352B2 (ja) * | 2008-03-14 | 2015-09-16 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | 複製欠損フラビウイルスワクチンおよびワクチンベクター |
| EP2257308A4 (en) * | 2008-03-27 | 2012-06-27 | Sanofi Pasteur Biologics Co | RECOMBINANT RHINOVIRUS VECTORS |
| EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| US20120128713A1 (en) * | 2009-03-16 | 2012-05-24 | Sanofi Pasteur Limited | Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus |
| EP2353609A1 (en) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Immunization compositions and methods |
| SG11201401733VA (en) * | 2011-10-25 | 2014-09-26 | Florida Gulf Coast University | Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes |
| SG10201912291YA (en) | 2012-07-24 | 2020-02-27 | Sanofi Pasteur | Vaccine compositions |
| AU2013295016A1 (en) * | 2012-07-24 | 2015-01-29 | Sanofi Pasteur | Vaccine compositions for prevention against dengue virus infection |
| BR112015012515B1 (pt) | 2012-11-30 | 2023-04-11 | Sanofi Pasteur | Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola |
| CN103352029A (zh) * | 2013-07-29 | 2013-10-16 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种乙脑/森林脑炎嵌合病毒及其应用 |
| WO2015196094A1 (en) * | 2014-06-20 | 2015-12-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric west nile/dengue viruses and methods of use |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| EP3031923A1 (en) * | 2014-12-11 | 2016-06-15 | Institut Pasteur | Lentiviral vector-based japanese encephalitis immunogenic composition |
| EP3316905A1 (en) | 2015-07-03 | 2018-05-09 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| BE1024160B9 (fr) | 2015-12-22 | 2017-12-06 | Glaxosmithkline Biologicals Sa | Formulation immunogène |
| EP3184119A1 (en) | 2015-12-23 | 2017-06-28 | Themis Bioscience GmbH | Chromatography based purification strategies for measles scaffold based viruses |
| KR20260047644A (ko) | 2017-03-30 | 2026-04-08 | 더 유니버서티 어브 퀸슬랜드 | 키메라 분자 및 그의 용도 |
| EP3687561A4 (en) | 2017-09-01 | 2021-06-09 | The Australian National University | "immunoregulatory molecules and uses therefor" |
| WO2019069130A1 (en) | 2017-10-05 | 2019-04-11 | Sanofi Pasteur | COMPOSITIONS FOR RECALL VACCINATION AGAINST DENGUE |
| AU2020273263A1 (en) * | 2019-04-10 | 2021-12-02 | Katholieke Universiteit Leuven | Chimeric Zika-Japanese encephalitis virus |
| CN111798712B (zh) * | 2020-07-15 | 2021-10-29 | 周晓庆 | 噬菌体侵染细菌3d智能模拟方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184024B1 (en) * | 1988-07-14 | 2001-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and/or growth-restricted flaviviruses |
| EP1018556B1 (en) | 1991-09-19 | 2005-11-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of HEALTH AND HUMAN SERVICES | Chimeric and/or growth-restricted flaviviruses |
| US6136561A (en) * | 1995-05-24 | 2000-10-24 | Hawaii Biotechnology Group, Inc. | Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems |
| US6962708B1 (en) * | 1997-02-28 | 2005-11-08 | Acambis, Inc. | Chimeric flavivirus vaccines |
| EP0977587B1 (en) | 1997-02-28 | 2005-06-15 | Acambis Inc. | Chimeric flavivirus vaccines |
| BRPI9701774B8 (pt) * | 1997-04-11 | 2015-09-29 | Fundação Oswaldo Cruz Fiocruz | cdna mutante e infeccioso do vírus da febre amarela, constructo de dna, vírus recombinante de febre amarela e vacina para humanos contra infecções de febre amarela. |
| US6416763B1 (en) * | 1998-08-28 | 2002-07-09 | Hawaii Biotechnology Group, Inc. | Recombinant nonstructural protein subunit vaccine against flaviviral infection |
| KR20020030793A (ko) * | 1999-08-20 | 2002-04-25 | 리차드 에이취 리저 | β-글루쿠로니다제를 억제시키는 데에 사용되는아스파르트산 및 말산의 용도 |
| AU1813901A (en) | 1999-12-01 | 2001-06-12 | Oravax, Inc | Chimeric flavivirus vaccines |
| GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
| CN1551782A (zh) * | 2001-06-01 | 2004-12-01 | ��������ķ������ | 嵌合黄病毒载体 |
| US6682883B1 (en) * | 2001-07-19 | 2004-01-27 | Acambis, Inc. | Diagnosis of flavivirus infection |
| KR101131579B1 (ko) | 2001-10-19 | 2012-03-30 | 사노피 파스테르 바이오로직스 씨오 | 동물의 플라비바이러스 감염 예방 및 치료 방법 |
| KR101074175B1 (ko) | 2002-01-15 | 2011-10-14 | 사노피 파스테르 바이오로직스 씨오 | 플라비바이러스 백신 |
| US20050002968A1 (en) * | 2002-01-15 | 2005-01-06 | Monath Thomas P. | Flavivirus vaccines |
| US20040259224A1 (en) * | 2002-05-31 | 2004-12-23 | Farshad Guirakhoo | Tetravalent Dengue vaccines |
| WO2004045529A2 (en) | 2002-11-15 | 2004-06-03 | Acambis, Inc. | West nile virus vaccine |
| US7189403B2 (en) * | 2003-06-30 | 2007-03-13 | Institut Pasteur | Attenuated flavivirus strains containing a mutated M-ectodomain and their applications |
| WO2005040390A1 (en) | 2003-07-21 | 2005-05-06 | Shanghai Tengen Biomedical Co., Ltd. | A recombinant vaccine using yellow fever virus as vector |
| WO2005049815A1 (en) | 2003-11-21 | 2005-06-02 | K.U.Leuven Research & Development | Flavivirus replication |
| SG156666A1 (en) | 2004-10-20 | 2009-11-26 | Acambis Inc | Vaccines against japanese encephalitis virus and west nile virus |
| CA2605924A1 (en) | 2005-04-24 | 2006-11-02 | Acambis Inc. | Recombinant flavivirus vaccines |
| BRPI0504945B8 (pt) | 2005-10-31 | 2022-08-02 | Fundacao Oswaldo Cruz | Método para a produção de flavivirus recombinante contendo sequências de nucleotídeos codificantes de uma proteína heteróloga, constructo de dna, flavivirus, e, composição vacinal para imunizar contra flavivirus e/ou outros patógenos. |
-
2002
- 2002-05-31 CN CNA028149602A patent/CN1551782A/zh active Pending
- 2002-05-31 KR KR1020037015734A patent/KR100921592B1/ko not_active Expired - Fee Related
- 2002-05-31 CA CA2448971A patent/CA2448971C/en not_active Expired - Fee Related
- 2002-05-31 ES ES02756112.5T patent/ES2439724T3/es not_active Expired - Lifetime
- 2002-05-31 PL PL02371187A patent/PL371187A1/xx not_active Application Discontinuation
- 2002-05-31 US US10/160,939 patent/US7569383B2/en not_active Expired - Fee Related
- 2002-05-31 WO PCT/US2002/017374 patent/WO2002102828A2/en not_active Ceased
- 2002-05-31 JP JP2003506300A patent/JP2005501532A/ja active Pending
- 2002-05-31 AU AU2002322026A patent/AU2002322026B2/en not_active Ceased
- 2002-05-31 BR BR0210907-7A patent/BR0210907A/pt not_active IP Right Cessation
- 2002-05-31 EP EP02756112.5A patent/EP1401859B1/en not_active Expired - Lifetime
-
2009
- 2009-07-14 US US12/460,110 patent/US20110014229A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005501532A5 (https=) | ||
| DK1113816T3 (da) | Influenzavirus-vaccinesammensætning | |
| EA200401064A1 (ru) | Вирусоподобные частицы из вируса папилломы человека | |
| EP2275131A3 (en) | HCV Vaccines | |
| JP2004538039A5 (https=) | ||
| EP1741782A9 (en) | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof | |
| JP2002524024A5 (https=) | ||
| JP2003160581A5 (https=) | ||
| EP2368576A3 (en) | Functionally reconstituted viral membranes containing adjuvant | |
| EP2290091A3 (en) | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions | |
| IS7830A (is) | Bóluefni gegn lifrarbólgu C veiru (HCV) | |
| DE60330966D1 (de) | Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber | |
| DE60042816D1 (de) | T-helferzellen-epitope | |
| EP1399481A4 (en) | RECOMBINANT ANTIBODIES TO INFECTIOUS BURSAL DISEASE VIRUS (IBDV) | |
| EP1392842A4 (en) | RECOMBINANT VACCINIA VIRUS VECTORS | |
| JP2005534326A5 (https=) | ||
| DK1002092T3 (da) | Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf | |
| JP2005517783A5 (https=) | ||
| JP2007516701A5 (https=) | ||
| DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| JP2006022119A5 (https=) | ||
| RU2000125255A (ru) | 2',3'-дидегидро-2',3'-дидезокситимидин-5'[(этоксикарбонил)(этил)фосфонат]- ингибитор репродукции вируса иммунодефицита человека | |
| AU2002952524A0 (en) | Epstein barr virus peptide epitopes | |
| JP2003284553A5 (https=) | ||
| RU2001127052A (ru) | Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов |